Cited by 189Heart Rate Variability and Autonomic ControlCardiac Health and Mental HealthMental Health Research Topics

Effects of Depression, Anxiety, Comorbidity, and Antidepressants on Resting-State Heart Rate and Its Variability: An ELSA-Brasil Cohort Baseline Study

Kemp, Andrew H., Brunoni, Andre R., Santos, Itamar S., Nunes, Maria A., Dantas, Eduardo M., Carvalho de Figueiredo, Roberta, Pereira, Alexandre C., Ribeiro, Antonio L.P. +5 more·2014·American Journal of Psychiatry

Abstract

OBJECTIVE: Increases in resting-state heart rate and decreases in its variability are associated with substantial morbidity and mortality, yet contradictory findings have been reported for the effects of the mood and anxiety disorders and of antidepressants. The authors investigated heart rate and heart rate variability in a large cohort from Brazil, using propensity score weighting, a relatively novel method, to control for numerous potential confounders. METHOD: A total of 15,105 participants were recruited in the Brazilian Longitudinal Study of Adult Health. Mood and anxiety disorders were ascertained using the Portuguese version of the Clinical Interview Schedule-Revised. Heart rate and its variability were extracted from 10-minute resting-state electrocardiograms. Regressions weighted by propensity scores were carried out to compare participants with and without depressive or anxiety disorders, as well as users and non-users of antidepressants, on heart rate and heart rate variability. RESULTS: Use of antidepressants was associated with increases in heart rate and decreases in its variability. Effects were most pronounced for the tricyclic antidepressants (Cohen's d, 0.72-0.81), followed by serotonin and norepinephrine reuptake inhibitors (Cohen's d, 0.42-0.95) and other antidepressants (Cohen's d, 0.37-0.40), relative to participants not on antidepressants. Only participants with generalized anxiety disorder showed robust, though small, increases in heart rate and decreases in its variability after propensity score weighting. CONCLUSIONS: The findings may, in part, underpin epidemiological findings of increased risk for cardiovascular morbidity and mortality. Many factors that have an adverse impact on cardiac activity were controlled for in this study, highlighting the importance of cardiovascular risk reduction strategies. Further study is needed to examine whether, how, and when such effects contribute to morbidity and mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2014.13121605

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Novel analytical methods such as propensity score weighting using generalized boosted modeling may help overcome limitations of traditional analysis, but are yet to be applied to associations between HRV and wellbeing.

    “Novel analytical methods such as propensity score weighting using generalized boosted modeling may help to overcome the limitations of traditional analysis (e.g., Kemp et al., 2014), but are yet to be applied to associations between HRV and wellbeing.”

    From The Complex Construct of Wellbeing and the Role of Vagal Function (2022) · cites this paper as Kemp et al., 2014

  • Basal heart rate was lower in patients taking SSRIs (mean=65.40 bpm, p=0.003, d=0.161) than in patients taking placebo.

    “Interestingly, the basal heart rate was lower in patients taking SSRIs (mean=65.40 bpm, p=0.003, d=0.161) than in patients taking the placebo (Table 1).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kemp, A. H., Brunoni, A. R., Santos, I. S., Nunes, M. A., Dantas, E. M., Carvalho de Figueiredo, R., Pereira, A. C., Ribeiro, A. L. P., Mill, J. G., Andreão, R. V., Thayer, J. F., Benseñor, I. M., & Lotufo, P. A.
Affiliations
  • The University of Sydney (AU)
  • From University Hospital and the Faculty of Medicine, University of São Paulo, São Paulo, Brazil; the School of Psychology and Discipline of Psychiatry, University of Sydney, Sydney, Australia; the Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; the Collegiate of Biological Sciences, Federal University of Vale do São Francisco, Petrolina, Pernambuco, Brazil; Campus Centro Oeste Dona Lindu, Federal University of São João Del-Rei, Brazil; the Laboratory of Genetics and...
Venue
American Journal of Psychiatry
Published
2014-12-01
Volume
171
Issue
12
Pages
1328-1334
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2119976990
Cited by
189
References
41
Citations by year
2026: 6 · 2025: 8 · 2024: 11 · 2023: 17 · 2022: 13 · 2021: 18 · 2020: 15 · 2019: 18 · 2018: 14 · 2017: 16 · 2016: 27 · 2015: 24 · 2014: 2
FWCI
15.77
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
Keywords
resting heart rate, heart rate variability, depression, anxiety disorders, antidepressants, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, generalized anxiety disorder, cardiovascular risk, mood disorders, ELSA-Brasil
MeSH terms
Adult, Aged, Antidepressive Agents, Antidepressive Agents, Tricyclic, Anxiety, Anxiety Disorders, Brazil, Cardiovascular Diseases, Depression, Major Depressive Disorder, Female, Heart Rate, Humans, Interview, Psychological, Longitudinal Studies, Male, Middle Aged, Vagus Nerve, Comorbidity, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Mood Disorders, Propensity Score

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review